Sign In
Skip Navigation Links
Skip navigation links
Home
Current Research
Resources
About NORDIC
Contact Us
IIHTT Study Sites
Skip Navigation LinksNORDIC Clinical Trials
Skip navigation links
About NORDIC
Mission Statement
NORDIC Policies
NORDIC Structure
NORDIC Executive Committee
Contact Us
IIHTT Study Sites
Welcome to NORDIC 
NORDIC Clinical Trials
 
 

 

 

The Neuro-Ophthalmology Research Disease Investigator Consortium (NORDIC) is a cohesive and extensive group of Neuro-Ophthalmologists, other doctors, coordinators, biostatisticians, clinical trial experts and reading centers, who have developed a structured organization to perform prospective clinical research with the support of the National Eye Institute of the NIH, other funding agencies, and industry.  Click here to read our mission statement.

Current Research

NORDIC is currently conducting one major study, Idiopathic Intracranial Hypertension Treatment Trial (IIHTT).  IIH, also called pseudotumor cerebri, is a disorder of elevated intracranial pressure of unknown case. Its incidence is 22.5 new cases each year per 100,000 overweight women of childbearing age; its incidence is rising in parallel with the obesity epidemic. It affects about 100,000 Americans. Learn more about this study by clicking here.

Optical Coherence Tomography as Measure of the Effects of Glatiramer Acetate on Axonal Loss in Patients with Acute Optic Neuritis (OCTAGON).  Learn more by clicking here.

Boehringer Ingelheim Pharmaceuticals.  Learn more by clicking here.

Safety Study of a Single IVT Injection of QPI-1007 in Chronic Optic Nerve Atrophy and Recent Onset NAION Patients                     Learn more by clicking here.

NEI and NORDIC are sponsoring the Idiopathic Intracranial Hypertension Treatment Trial      Learn more by clicking here. 

 

 Propose Research Idea

 Click here to download New Project Proposal Template

 

 Become a Study Participant    Become an Investigator
 
 NORDIC Study Team    Industry Sponsors